Respiratory tract microbiome US Medical PG Practice Questions and MCQs
Practice US Medical PG questions for Respiratory tract microbiome. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Respiratory tract microbiome US Medical PG Question 1: An investigator is studying the growth of an organism in different media. The organism is inoculated on a petri dish that contains heated sheep blood, vancomycin, nystatin, trimethoprim, and colistin. The resulting growth medium is incubated at 37°C. Numerous small, white colonies are seen after incubation for 48 hours. This organism is most likely to cause which of the following conditions?
- A. Pontiac fever
- B. Pseudomembranous colitis
- C. Hemolytic uremic syndrome
- D. Oral thrush
- E. Gonorrhea (Correct Answer)
Respiratory tract microbiome Explanation: ***Gonorrhea***
- The growth medium described is **Thayer-Martin agar**, a selective medium containing **heated sheep blood** (supplies NAD+), **vancomycin** (inhibits Gram-positives), **colistin** (inhibits Gram-negatives), **nystatin** (inhibits fungi), and **trimethoprim** (inhibits Proteus). This medium is specifically designed for the isolation of *Neisseria gonorrhoeae* from polymicrobial samples.
- *Neisseria gonorrhoeae* typically grows as **small, translucent-to-white colonies** on selective media like Thayer-Martin agar, and incubation at 37°C in CO2 (not explicitly mentioned but often required) for 24-48 hours yields visible growth, causing **gonorrhea**.
*Pontiac fever*
- Pontiac fever is a mild, self-limiting form of **legionellosis**, caused by *Legionella pneumophila*.
- *Legionella* requires a specialized medium such as **buffered charcoal yeast extract (BCYE) agar** for growth, not Thayer-Martin agar.
*Pseudomembranous colitis*
- This condition is caused by **toxin-producing *Clostridioides difficile***, often after antibiotic use.
- *C. difficile* is an obligate anaerobe and requires **anaerobic conditions** and specific selective media (e.g., CCFA agar) for isolation, not Thayer-Martin agar under aerobic conditions.
*Hemolytic uremic syndrome*
- Hemolytic uremic syndrome (HUS) is often caused by **Shiga toxin-producing *Escherichia coli* (STEC)**, particularly O157:H7.
- STEC can be isolated on media like **sorbitol MacConkey agar (SMAC)**, where O157:H7 appears as non-sorbitol fermenting colonies, distinct from the growth seen on Thayer-Martin.
*Oral thrush*
- Oral thrush is caused by *Candida albicans*, a yeast.
- *Candida* would be inhibited by **nystatin** in the Thayer-Martin medium, which is an antifungal agent.
Respiratory tract microbiome US Medical PG Question 2: A 40-year-old man presents to the office complaining of chills, fever, and productive cough for the past 24 hours. He has a history of smoking since he was 18 years old. His vitals are: heart rate of 85/min, respiratory rate of 20/min, temperature 39.0°C (102.2°F), blood pressure 110/70 mm Hg. On physical examination, there is dullness on percussion on the upper right lobe, as well as bronchial breath sounds and egophony. The plain radiograph reveals an increase in density with an alveolar pattern in the upper right lobe. Which one is the most common etiologic agent of the suspected disease?
- A. Legionella pneumophila
- B. Chlamydia pneumoniae
- C. Mycoplasma pneumoniae
- D. Streptococcus pneumoniae (Correct Answer)
- E. Haemophilus influenzae
Respiratory tract microbiome Explanation: ***Streptococcus pneumoniae***
- This patient presents with classic symptoms of **community-acquired pneumonia (CAP)**, including fever, chills, productive cough, and specific findings on physical exam (dullness, bronchial breath sounds, egophony) and chest X-ray (**lobar consolidation**).
- **_Streptococcus pneumoniae_** is the most common bacterial cause of CAP worldwide, accounting for a significant percentage of cases, especially in adults.
*Legionella pneumophila*
- While _Legionella_ can cause severe pneumonia, it often presents with **GI symptoms** (diarrhea, nausea) and **neurological symptoms** (confusion) in addition to respiratory symptoms, which are not described here.
- Risk factors typically include exposure to **contaminated water sources**, and the pneumonia can be rapidly progressive.
*Chlamydia pneumoniae*
- _Chlamydia pneumoniae_ typically causes a more **atypical pneumonia**, often with a more insidious onset, prolonged cough, and less severe systemic symptoms.
- It usually presents as a **walking pneumonia** with milder findings on chest X-ray, unlike the clear lobar consolidation described.
*Mycoplasma pneumoniae*
- Like _Chlamydia pneumoniae_, _Mycoplasma pneumoniae_ is a common cause of **atypical pneumonia**, often with a gradual onset, hacking cough, and less pronounced fever.
- It rarely causes the classic lobar consolidation seen in this patient and is often referred to as "walking pneumonia."
*Haemophilus influenzae*
- _Haemophilus influenzae_ is a significant cause of CAP, especially in patients with **underlying lung disease** (like COPD) or other comorbidities.
- While certainly a possibility given the patient's smoking history, **_Streptococcus pneumoniae_** remains the overall most common cause of bacterial CAP in otherwise healthy adults.
Respiratory tract microbiome US Medical PG Question 3: A patient is hospitalized for pneumonia. Gram-positive cocci in clusters are seen on sputum gram stain. Which of the following clinical scenarios is most commonly associated with this form of pneumonia?
- A. Elderly patient who has trouble swallowing and poor dentition
- B. An alcoholic with evidence of empyema and "currant jelly sputum"
- C. An otherwise healthy young adult with a week of mild fatigue, chills, and cough
- D. Hospitalized adult with development of pneumonia symptoms 2 weeks following a viral illness (Correct Answer)
- E. HIV positive adult with a CD4 count less than 150 and an impaired diffusion capacity
Respiratory tract microbiome Explanation: ***Hospitalized adult with development of pneumonia symptoms 2 weeks following a viral illness***
- Gram-positive cocci in clusters suggests **Staphylococcus aureus**, which is a common cause of secondary bacterial pneumonia, often following **viral illnesses** (e.g., influenza).
- This scenario represents a classic presentation of **secondary bacterial pneumonia**, where the initial viral infection compromises the respiratory defenses, allowing bacterial superinfection.
*Elderly patient who has trouble swallowing and poor dentition*
- This scenario points towards **aspiration pneumonia**, often caused by a **polymicrobial infection** that includes oral anaerobes, not typically dominated by Gram-positive cocci in clusters.
- While *S. aureus* can cause aspiration pneumonia, the primary concern in this context would be **anaerobic bacteria**, given the aspiration risk factors.
*An alcoholic with evidence of empyema and \"currant jelly sputum\"*
- This description is highly suggestive of **Klebsiella pneumoniae** infection, which typically presents with thick, gelatinous, and often **blood-tinged sputum**.
- **Klebsiella** is a Gram-negative rod, not Gram-positive cocci in clusters.
*An otherwise healthy young adult with a week of mild fatigue, chills, and cough*
- This presentation is more consistent with **atypical pneumonia** caused by organisms like **Mycoplasma pneumoniae** or **Chlamydophila pneumoniae**, which would not show Gram-positive cocci in clusters on sputum stain.
- **Streptococcus pneumoniae** (Gram-positive cocci in chains) can also cause community-acquired pneumonia in otherwise healthy individuals, but the "clusters" indicate **Staphylococcus aureus**.
*HIV positive adult with a CD4 count less than 150 and an impaired diffusion capacity*
- This clinical picture strongly suggests **Pneumocystis jirovecii pneumonia (PJP)**, which is common in severely immunocompromised HIV patients.
- *P. jirovecii* is a fungus and would not be seen as Gram-positive cocci in clusters on a routine Gram stain.
Respiratory tract microbiome US Medical PG Question 4: A 28-year-old male presents to his primary care physician with complaints of intermittent abdominal pain and alternating bouts of constipation and diarrhea. His medical chart is not significant for any past medical problems or prior surgeries. He is not prescribed any current medications. Which of the following questions would be the most useful next question in eliciting further history from this patient?
- A. "Does the diarrhea typically precede the constipation, or vice-versa?"
- B. "Is the diarrhea foul-smelling?"
- C. "Please rate your abdominal pain on a scale of 1-10, with 10 being the worst pain of your life"
- D. "Are the symptoms worse in the morning or at night?"
- E. "Can you tell me more about the symptoms you have been experiencing?" (Correct Answer)
Respiratory tract microbiome Explanation: ***Can you tell me more about the symptoms you have been experiencing?***
- This **open-ended question** encourages the patient to provide a **comprehensive narrative** of their symptoms, including details about onset, frequency, duration, alleviating/aggravating factors, and associated symptoms, which is crucial for diagnosis.
- In a patient presenting with vague, intermittent symptoms like alternating constipation and diarrhea, allowing them to elaborate freely can reveal important clues that might not be captured by more targeted questions.
*Does the diarrhea typically precede the constipation, or vice-versa?*
- While knowing the sequence of symptoms can be helpful in understanding the **pattern of bowel dysfunction**, it is a very specific question that might overlook other important aspects of the patient's experience.
- It prematurely narrows the focus without first obtaining a broad understanding of the patient's overall symptomatic picture.
*Is the diarrhea foul-smelling?*
- Foul-smelling diarrhea can indicate **malabsorption** or **bacterial overgrowth**, which are important to consider in some gastrointestinal conditions.
- However, this is a **specific symptom inquiry** that should follow a more general exploration of the patient's symptoms, as it may not be relevant if other crucial details are missed.
*Please rate your abdominal pain on a scale of 1-10, with 10 being the worst pain of your life*
- Quantifying pain intensity is useful for assessing the **severity of discomfort** and monitoring changes over time.
- However, for a patient with intermittent rather than acute, severe pain, understanding the **character, location, and triggers** of the pain is often more diagnostically valuable than just a numerical rating initially.
*Are the symptoms worse in the morning or at night?*
- Diurnal variation can be relevant in certain conditions, such as inflammatory bowel diseases where nocturnal symptoms might be more concerning, or functional disorders whose symptoms might be stress-related.
- This is another **specific question** that should come after gathering a more complete initial picture of the patient's symptoms to ensure no key information is overlooked.
Respiratory tract microbiome US Medical PG Question 5: A 35-year-old man comes to the emergency department with fever, chills, dyspnea, and a productive cough. His symptoms began suddenly 2 days ago. He was diagnosed with HIV 4 years ago and has been on triple antiretroviral therapy since then. He smokes one pack of cigarettes daily. He is 181 cm (5 ft 11 in) tall and weighs 70 kg (154 lb); BMI is 21.4 kg/m2. He lives in Illinois and works as a carpenter. His temperature is 38.8°C (101.8°F), pulse is 110/min, respirations are 24/min, and blood pressure is 105/74 mm Hg. Pulse oximetry on room air shows an oxygen saturation of 92%. Examinations reveals crackles over the right lower lung base. The remainder of the examination shows no abnormalities. Laboratory studies show:
Hemoglobin 11.5 g/dL
Leukocyte count 12,800/mm3
Segmented neutrophils 80%
Eosinophils 1%
Lymphocytes 17%
Monocytes 2%
CD4+ T-lymphocytes 520/mm3(N ≥ 500)
Platelet count 258,000/mm3
Serum
Na+ 137 mEq/L
Cl- 102 mEq/L
K+ 5.0 mEq/L
HCO3- 22 mEq/L
Glucose 92 mg/dL
An x-ray of the chest shows a right lower-lobe infiltrate of the lung. Which of the following is the most likely causal organism?
- A. Streptococcus pneumoniae (Correct Answer)
- B. Legionella pneumophila
- C. Pneumocystis jirovecii
- D. Staphylococcus aureus
- E. Cryptococcus neoformans
Respiratory tract microbiome Explanation: ***Streptococcus pneumoniae***
- This patient presents with **fever, chills, productive cough, dyspnea, leukocytosis with neutrophilia, and a lobar infiltrate on chest X-ray**, which are classic signs of **community-acquired bacterial pneumonia**.
- Although the patient is **HIV-positive**, his CD4+ count is >500/mm3 and he is on antiretroviral therapy, indicating relatively preserved immune function, making *S. pneumoniae* the most common cause of pneumonia even in HIV-infected individuals with controlled disease.
*Legionella pneumophila*
- While *Legionella* can cause pneumonia with fever and dyspnea, it is often associated with **gastrointestinal symptoms** (e.g., diarrhea) and **hyponatremia**, which are not present here.
- Exposure to contaminated water sources is a common risk factor, and the lobar infiltrate is less typical than diffuse or patchy infiltrates.
*Pneumocystis jirovecii*
- *Pneumocystis pneumonia (PJP)* is typically seen in **HIV patients with severely suppressed immune systems (CD4+ count <200/mm3)**.
- The patient's CD4+ count (520/mm3) is above this threshold, and PJP usually presents with diffuse interstitial infiltrates rather than a lobar infiltrate.
*Staphylococcus aureus*
- *S. aureus* pneumonia often occurs in the context of recent **influenza infection, intravenous drug use, or hospitalization**, or can present rapidly with **necrotizing pneumonia** or **empyema**.
- While possible, the absence of these specific risk factors or severe features makes it less likely than *S. pneumoniae* in this specific presentation.
*Cryptococcus neoformans*
- *Cryptococcus neoformans* is an opportunistic fungus that typically causes **pulmonary or central nervous system infections**, especially in severely immunocompromised patients (CD4+ count usually <100/mm3).
- Pulmonary cryptococcosis often manifests as **nodules or cavitary lesions**, or can be asymptomatic, which differs from the acute lobar pneumonia presented.
Respiratory tract microbiome US Medical PG Question 6: While testing various strains of Streptococcus pneumoniae, a researcher discovers that a certain strain of this bacteria is unable to cause disease in mice when deposited in their lungs. What physiological test would most likely deviate from normal in this strain of bacteria as opposed to a typical strain?
- A. Quellung reaction (Correct Answer)
- B. Hemolytic reaction when grown on sheep blood agar
- C. Bile solubility
- D. Optochin sensitivity
- E. Motility
Respiratory tract microbiome Explanation: ***Quellung reaction***
- The **Quellung reaction** tests for the presence of the **polysaccharide capsule**, which is the primary virulence factor of *S. pneumoniae*.
- An **avirulent strain** that cannot cause disease would most likely lack the capsule and show a **negative Quellung reaction** (no capsular swelling), deviating from the **positive reaction** seen in typical encapsulated pathogenic strains.
- The capsule enables *S. pneumoniae* to evade phagocytosis and complement-mediated killing, which is essential for establishing infection in the lungs.
*Hemolytic reaction when grown on sheep blood agar*
- Both virulent and avirulent strains of *S. pneumoniae* typically exhibit **alpha-hemolysis** (partial hemolysis, producing a greenish discoloration) on sheep blood agar due to the production of pneumolysin.
- This characteristic does not differentiate between pathogenic and non-pathogenic strains in terms of disease-causing ability.
*Bile solubility*
- *S. pneumoniae* is characteristically **bile-soluble** due to the presence of autolysin enzymes that are activated by bile salts, leading to cellular lysis.
- This property is a **species characteristic** present in both virulent and avirulent strains, thus it would not explain the inability to cause disease.
*Optochin sensitivity*
- *S. pneumoniae* is universally **sensitive to optochin**, a chemical agent that inhibits its growth and is used for laboratory identification.
- This characteristic is used for **species identification** but does not correlate with strain virulence or disease-causing ability.
*Motility*
- *Streptococcus pneumoniae* is a **non-motile** bacterium; it lacks flagella.
- This characteristic is consistent across all strains and is not a virulence factor for this species.
Respiratory tract microbiome US Medical PG Question 7: A 46-year-old woman presents to her primary care physician with complaints of increasing left upper quadrant discomfort. She has a known history of type 1 Gaucher disease. On physical examination, her spleen is palpable 8 cm below the costal margin. Routine laboratory work reveals severe pancytopenia. After consultation with the patient on the risks of her condition, the patient decides to undergo a splenectomy. Which of the following is more likely to occur as a consequence of splenectomy in this patient?
- A. Thrombocytopenia
- B. Leukopenia
- C. Pneumococcal septicemia (Correct Answer)
- D. Staphylococcal septicemia
- E. Anemia
Respiratory tract microbiome Explanation: ***Pneumococcal septicemia***
- Patients who undergo splenectomy are at significantly increased risk of **overwhelming post-splenectomy infection (OPSI)**, particularly from **encapsulated bacteria** like *Streptococcus pneumoniae*.
- The spleen plays a crucial role in filtering encapsulated bacteria and producing opsonizing antibodies, and its removal compromises this immune function.
*Thrombocytopenia*
- **Thrombocytopenia** is typically a symptom *before* splenectomy in Gaucher disease due to hypersplenism.
- After splenectomy, the platelet count often **increases**, not decreases, due to the removal of the organ that sequesters platelets and destroys them.
*Leukopenia*
- **Leukopenia** (specifically neutropenia) is a pre-existing condition in severe Gaucher disease due to hypersplenism and bone marrow involvement.
- Post-splenectomy, the white blood cell count, particularly neutrophils, generally **increases** as the sequestration and destruction in the spleen are eliminated.
*Staphylococcal septicemia*
- While *Staphylococcus* can cause serious infections, it is **not the primary pathogen** associated with OPSI in asplenic patients.
- Encapsulated bacteria like *Streptococcus pneumoniae* are the most common and dangerous cause of post-splenectomy sepsis.
*Anemia*
- **Anemia** is a common finding in Gaucher disease due to hypersplenism and bone marrow infiltration.
- Splenectomy typically **improves** anemia by removing the site of red blood cell destruction and reducing abnormal cytokine production that inhibits erythropoiesis.
Respiratory tract microbiome US Medical PG Question 8: A hospital implements a bundle to reduce catheter-associated bloodstream infections. Components include: chlorhexidine bathing, antibiotic-impregnated catheters, antiseptic catheter site dressings, and daily line necessity assessment. After implementation, bloodstream infections with coagulase-negative staphylococci decrease by 60%, but Candida bloodstream infections increase by 40%. Evaluate the microbiological mechanisms underlying these divergent outcomes and synthesize an optimal prevention strategy.
- A. Antibiotic-impregnated catheters select for resistant Candida; use non-antibiotic catheters
- B. The bundle successfully reduced bacterial infections, revealing underlying fungal infections; add antifungal prophylaxis
- C. Multiple interventions disrupted skin flora creating ecological niche for Candida; modify bundle to preserve some commensal bacteria while maintaining antisepsis (Correct Answer)
- D. Chlorhexidine bathing eliminates bacterial skin flora but promotes fungal colonization; discontinue chlorhexidine
- E. Candida increase represents surveillance bias from increased culturing; no change needed
Respiratory tract microbiome Explanation: ***Multiple interventions disrupted skin flora creating ecological niche for Candida; modify bundle to preserve some commensal bacteria while maintaining antisepsis***
- Aggressive use of **chlorhexidine bathing** and **antibiotic-impregnated catheters** eliminates commensal bacterial flora that provide **colonization resistance** against opportunistic fungi.
- The reduction in **Coagulase-negative staphylococci** creates an available **ecological niche**, allowing *Candida* species to proliferate and colonize the catheter site more effectively.
*Antibiotic-impregnated catheters select for resistant Candida; use non-antibiotic catheters*
- While **antibiotic-impregnated catheters** reduce bacterial biofilm, they do not directly "select" for resistance in fungi, as antibiotics have no biochemical target in *Candida*.
- Removing them entirely may lead to a rebound in **staphylococcal infections**, failing to address the need for a balanced antiseptic strategy.
*The bundle successfully reduced bacterial infections, revealing underlying fungal infections; add antifungal prophylaxis*
- Adding **antifungal prophylaxis** as a routine measures increases the risk of developing **drug-resistant fungal strains** like *Candida auris*.
- This approach ignores the ecological disruption caused by the bundle and instead layers on more **antimicrobial pressure**, which is rarely a sustainable prevention strategy.
*Chlorhexidine bathing eliminates bacterial skin flora but promotes fungal colonization; discontinue chlorhexidine*
- Discontinuing **chlorhexidine bathing** would likely reverse the 60% reduction in **coagulase-negative staphylococcal** infections, which are a major source of morbidity.
- The goal should be optimization (e.g., targeted use or modified frequency) rather than total discontinuation of an effective **infection control** tool.
*Candida increase represents surveillance bias from increased culturing; no change needed*
- A 40% increase in **Candida bloodstream infections** is a significant clinical shift that requires a root-cause analysis rather than dismissal as **surveillance bias**.
- "No change needed" is incorrect because the bundle has created a new, clinically significant risk for **iatrogenic candidemia**.
Respiratory tract microbiome US Medical PG Question 9: A 68-year-old man develops Clostridioides difficile infection after hospitalization for pneumonia. He is treated with oral vancomycin with resolution of diarrhea. Two weeks later, he has recurrent C. difficile infection. After a second vancomycin course, he has a third recurrence. His physician must choose between extended vancomycin taper, fidaxomicin, or fecal microbiota transplantation (FMT). Synthesize the microbiological rationale for selecting FMT over continued antibiotic therapy in recurrent C. difficile infection.
- A. FMT restores colonization resistance that prevents C. difficile recurrence better than antibiotics that further disrupt flora (Correct Answer)
- B. FMT treats antibiotic-resistant C. difficile strains unresponsive to vancomycin
- C. FMT provides immune modulation that antibiotics cannot achieve
- D. FMT eradicates C. difficile spores more effectively than antibiotics
- E. FMT is more cost-effective than prolonged antibiotic courses
Respiratory tract microbiome Explanation: ***FMT restores colonization resistance that prevents C. difficile recurrence better than antibiotics that further disrupt flora***
- Recurrent **Clostridioides difficile** infection (CDI) is driven by a persistent state of **dysbiosis** where the normal gut microbiome fails to inhibit spore germination and vegetative growth.
- **Fecal Microbiota Transplantation (FMT)** reintroduces a diverse ecosystem of commensal bacteria that compete for nutrients and restore **secondary bile acid metabolism**, effectively restoring the gut's **colonization resistance**.
*FMT treats antibiotic-resistant C. difficile strains unresponsive to vancomycin*
- CDI recurrence is rarely due to **antibiotic resistance**; C. difficile remains highly susceptible to **vancomycin** and **fidaxomicin** in vitro.
- The failure of therapy is due to the survival of **dormant spores** in a disrupted microbiome, not the presence of resistant vegetative cells.
*FMT provides immune modulation that antibiotics cannot achieve*
- While the microbiome does interact with the immune system, the primary mechanism of FMT in treating CDI is **microbial competition** and metabolic restoration rather than systemic **immune modulation**.
- Antibiotics like **fidaxomicin** can also have minor anti-inflammatory effects, but this is not the rationale for choosing FMT over pharmacological therapy.
*FMT eradicates C. difficile spores more effectively than antibiotics*
- Neither antibiotics nor FMT directly "kill" or **eradicate spores**; spores are biologically inert and resistant to most environmental stressors.
- FMT works by preventing those spores from **germinating** into toxin-producing vegetative cells by restoring the inhibitory environment of a healthy gut.
*FMT is more cost-effective than prolonged antibiotic courses*
- While FMT may be **cost-effective** in the long term by preventing further hospitalizations, this is a pharmacoeconomic rationale rather than a **microbiological** one.
- The question specifically asks for the **microbiological rationale**, which pertains to the restoration of the ecological balance of the gut flora.
Respiratory tract microbiome US Medical PG Question 10: A research team is designing a probiotic intervention to prevent Clostridioides difficile infection in patients receiving antibiotics. They must choose between: (1) single-strain Lactobacillus; (2) multi-strain bacterial cocktail; (3) fecal microbiota transplantation; (4) prebiotic fiber supplementation. Evaluate which approach best applies principles of colonization resistance and normal flora restoration for PRIMARY prevention during antibiotic therapy.
- A. Multi-strain bacterial cocktail best recreates colonization resistance
- B. Fecal microbiota transplantation most completely restores normal flora
- C. Prebiotic fiber selectively promotes beneficial flora growth
- D. Single-strain Lactobacillus provides simplest and safest intervention
- E. No intervention has proven efficacy for primary prevention during antibiotics (Correct Answer)
Respiratory tract microbiome Explanation: ***No intervention has proven efficacy for primary prevention during antibiotics***
- Despite theoretical benefits, clinical evidence does not support the routine use of probiotics or prebiotics for the **primary prevention** of *Clostridioides difficile* infection (CDI) while a patient is undergoing antibiotic therapy.
- Factors such as **antibiotic interference** with the probiotic strain's survival and the failure to achieve robust **engraftment** mean that **antibiotic stewardship** remains the only proven preventive strategy.
*Multi-strain bacterial cocktail best recreates colonization resistance*
- While **diverse microbiotas** are superior for **colonization resistance**, multi-strain probiotics are still killed or inhibited by the concurrent antibiotics being administered.
- They lack the complex **metabolic interactions** found in native flora required to successfully outcompete *C. difficile* spores during active antibiotic disruption.
*Fecal microbiota transplantation most completely restores normal flora*
- **Fecal microbiota transplantation (FMT)** is highly effective for treating **recurrent CDI**, but it is not indicated or validated for **primary prevention**.
- The complexity and risk profile of FMT make it unsuitable for routine use in patients simply starting a course of standard antibiotics.
*Prebiotic fiber selectively promotes beneficial flora growth*
- **Prebiotics** are non-digestible fibers intended to stimulate growth of "good" bacteria, but they cannot restore **bacterial diversity** when the source bacteria are being killed by antibiotics.
- There is currently **insufficient clinical evidence** to recommend prebiotics as a reliable method to prevent the onset of CDI in the clinical setting.
*Single-strain Lactobacillus provides simplest and safest intervention*
- **Single-strain probiotics** like *Lactobacillus* are often overwhelmed by the microbial shift (dysbiosis) caused by broad-spectrum antibiotics.
- These interventions are too simplified to mimic the **ecological niche protection** provided by the healthy, complex human microbiome.
More Respiratory tract microbiome US Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
